2024 Annual Report

In 2024, our amazing Fred Hutch Obliteride community set new records. More of us than ever before biked, walked, ran, volunteered, and fundraised to help cure cancer faster! We raised a record-breaking $9,071,712 to help Fred Hutch Cancer Center advance prevention, detection, treatment and cures — bringing our 12-year total to $58 million. And our strength goes even further than these numbers. It’s every starting-line cheer. Every “I’ve got you” and “you’ve got this.” It's every one of us, doing more than we ever thought possible to turn our love into action. Explore this report to see our impact and celebrate our extraordinary year!

2024 by the Numbers

Our Impact

Who We Are

12 Years Strong

Our Generous Sponsors

100% of participant-raised dollars support groundbreaking work at Fred Hutch, thanks to generous event sponsors and supporters.

Thank You!

2024 by the Numbers

From one to … amazing! Obliteriders set new records in 2024, proving that when we put our collective energy to work, we empower one another and help Fred Hutch advance transformative innovation. Check out who we are, how we participated, and some of our accomplishments.

$9M+

Raised to support Fred Hutch

6,260

Participants

486

Teams

814

Volunteers

1,911

Fred Hutch and UW Medicine employees

22,795

Donors
 

31,820

Donations received
 

42

Sponsors
 

How We Participated

Obliteriders clip in, lace up and make a difference. Here’s a look at how participants came together this year.

A colored chart showing how people participated in Obliteride.
A light orange circle

100-mile Ride
7%

An orange circle

5K Walk/Run
60%

A teal circle

50-mile Ride
12%

A purple circle

25-mile Ride
9%

A navy blue circle

Virtual
12%

Leaderboards

In 2024, these dedicated participants and teams went above and beyond, becoming leaders and inspiring their communities. Their dedication, and the support of their donors, is crucial to Fred Hutch. Together, we are pushing the limits of science, pursuing every opportunity, and advancing research to cure cancer faster. As of November 14, 2024.

Top 5 Individuals
Most Raised
NAMEAMOUNT
Molly Nordstrom Sloan$184,000
Marka Jenkins Waechter$76,300
Robb Carter$64,750
Jayashree Srinivasan$54,900
Harvey Kanter$41,889
Top 5 Corporate Teams
Most Raised
NAMEAMOUNT
Team Freestone$186,505
Lewis & Friends$174,425
Microsoft & Friends$99,242
Cascade Bicycle Studio / #WeRideWhy$91,260
Compass Construction$87,590
Top 5 Fred Hutch & UW Medicine Staff Teams
Most Raised
NAMEAMOUNT
Obliteraisers$56,820
Team iPCr$44,138
Skin in the Game$35,008
Orange Lanterns$27,270
Beet Cancer$25,161
Top 5 Friends & Family Teams
Most Raised
NAMEAMOUNT
Village People$306,158
LFP Cancer Crushers$87,487
Team Orange$78,710
Riders from the Rock$78,159
Smack Down Cancer$57,873
Top 5 Friends & Family Teams
Most Participants
NAMENUMBER
Team Rishi & Team Donna: Embrace the Suck140
Team Brian Dahl77
Team Z60
LFP Cancer Crushers59
Kristin & Company45
Top 5 Corporate Teams
Most Participants
NAMENUMBER
Edward Jones — Market 21194
Amazon144
Adaptive Biotechnologies61
Nordstrom56
Microsoft & Friends53

Personal and Powerful: Our Impact

Obliteride participants directed their fundraising to support the area of our work that is the most meaningful to them. Whether they chose a specific disease area, program, researcher, or clinician, or our general fund for top cancer research and care priorities, 100% of their fundraising fuels urgently needed advances at Fred Hutch.

Looking Beyond: Cancer Research and Care

Many Obliteriders chose to raise funds for Fred Hutch’s general fund for top cancer research and care priorities. We’re honored to have earned the trust of our community as we bring new findings in prevention, detection, and treatment to more people. Critical philanthropic support from Obliteride and other donors allows Fred Hutch to:

  • Advance precision oncology and create effective treatments, diagnostic tools, and risk-reduction strategies tailored to more people and more types of cancer.
  • Attract and retain the world’s top scientists, train future generations, help them collaborate, and support their boldest ideas. 
  • Secure millions more in government and foundation dollars.
  • Build on 50 years of scientific leadership to look beyond today’s limits and translate discoveries into cures.

Passion and Action: Specific Disease Areas

In 2024, Obliteriders also fundraised for specific disease areas with special significance to them. Their fundraising accelerates discoveries to prevent, detect, treat, and cure cancer and infectious diseases.

27

Disease areas supported

Disease areas selected:

Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Bladder-urologic cancer
Breast cancer
Cervical cancer
Chronic myeloid leukemia (CML)
Colon cancer
Esophageal cancer
Gastrointestinal cancers

Gynecologic cancers
Hematologic cancers
HIV virus and vaccine research
Infectious disease research
Kidney/renal cancer
Leukemia
Lung cancer
Lymphoma
Melanoma

Merkel cell carcinoma
Multiple myeloma
Neuroendocrine tumors
Neurologic cancers
Ovarian cancer
Pancreatic cancers
Prostate cancer
Sarcoma
Thoracic, head, and neck cancers

Two researchers work together in a lab.
DISEASE AREA HIGHLIGHT

Lymphoma

Lymphomas are cancers that strike immune cells within the lymphatic system. Many cases can be cured. Our goal is to cure all cases and help people thrive. Fred Hutch scientists are developing and testing new drugs and advancing tests to guide treatment. Our research also includes long-term studies to understand how survivors fare years after treatment.

Passion and Purpose: People

Fred Hutch’s more than 5,700 researchers, clinicians, and staff collaborate across disciplines — asking big questions and unlocking insights that help us understand and intercept disease and bring new findings from the lab to the clinic. Obliteride support helps pave the way.

84

Faculty and clinicians supported

Faculty and clinicians selected:

Jennifer E Adair, PhD
James Alvarez, PhD
Garnet L Anderson, PhD
Kevin C Barry, PhD
Alice H Berger, PhD
Shailender Bhatia, MBBS
Marie Bleakley, MD
Christopher Blosser, MD
Jim Boonyaratanakornkit, MD, PhD
Phil Bradley, PhD
Jonathan B Bricker, PhD
Aude Chapuis, MD
Elena Gabriela Chiorean, MD
Eric J Chow, MD, MPH
Stacey Cohen, MD
Laura Connelly-Smith, MBBCh, DM
Lawrence Corey, MD
Andrew Coveler, MD
Jarrod A Dudakov, PhD
Keith Eaton, MD, PhD
Ralph Ermoian, MD
R. Failor, MD
Min Fang, MD, PhD
Scott Furlan, MD
Cyrus M Ghajar, PhD
Ajay Gopal, MD
William Grady, MD
Philip Greenberg, MD

Heather Greenlee, ND, PhD
Taran Gujral, PhD
Gavin Ha, PhD
Evan Hall, MD
Paul Hendrie, MD, PhD
Eric C Holland, MD, PhD
Hanna Hunter, MD
Natasha Hunter, MD
Rachel Issaka, MD
Mehrdad Jafari, MD, PhD
Nikhil Kamat, MD
Sioban Keel, MD
Hans-Peter Kiem, MD
Janice Kim, MD
Erik Kimble, MD
Elizabeth Krakow, MD
Sita Kugel, PhD
Johanna W Lampe, PhD, RD
Stephanie Lee, MD, MPH
Keith Loeb, MD, PhD
Elizabeth Loggers, MD, PhD
Emily Marchiano, MD
Kate Markey, MBBS, PhD
Soheil Meshinchi, MD, PhD
Filippo Milano, MD, PhD
Harveshp Mogal, MD
Peter Nelson, MD
Paul Nghiem, MD, PhD

Yaw Nyame, MD, MBA
Johnnie Orozco, MD, PhD
Katrina Ortblad, ScD, MPH
Julie M Overbaugh, PhD
Amanda I Phipps, PhD, MPH
Venu Pillarisetty, MD
W. Purcell, MD, MBA
Jerald Radich, MD
Vikram Raghunathan, MD
Stan Riddell, MD
Aaron Ring, MD, PhD
Cristina Rodriguez, MD
Anthony Rongvaux, PhD
Mara Roth, MD
Rachael Safyan, MD
Jonathan Sham, MD
Veena Shankaran, MD
Jeremy Sharib, MD
Megan Shen, PhD
Jennifer Specht, MD
Elizabeth Swisher, MD
John Thompson, MD
Brian Till, MD
Vyshak Alva Venur, MBBS
Trang M VoPham, PhD, MPH, MS
Jonathan L Wright, MD, MS, FACS
Cecilia Yeung, MD
Evan Yu, MD

Yaw A. Nyame, MD, MS, MBA
RESEARCHER HIGHLIGHT

Yaw A. Nyame, MD, MS, MBA

Black men and those of African descent are 60% more likely to be diagnosed with prostate cancer — and more than twice as likely to die from it. Dr. Nyame, a urologist and surgeon at Fred Hutch and UW Medicine (and an Obliterider) works with patients, the community, and advocates to understand the causes of this disparity, find solutions, and save lives.

Excellence and Innovation: Programs and Specialties

Fred Hutch looks beyond today’s options to find new approaches to prevent, treat, and cure cancer and infectious diseases. From bold research and dedicated patient support to community collaborations that help more people access care, Obliteride support helps our programs and specialties accelerate breakthroughs.

26

Programs and specialties supported

Programs and specialties selected:

Basic science
Cancer prevention and early detection
Cancer research
Cook for Your Life
Cord blood research
Data science
Data Science Lab (DaSL)
Emerging technologies and
     state-of-the-art equipment

Global oncology/Uganda
Health disparities research
HICOR
HSV gene therapy
Immunotherapy
Nursing excellence
Nursing research fund
Office of community outreach & engagement
Oral Medicine Clinic

Palliative care program
Patient and family assistance fund
Patient housing
Patient supportive services
Precision oncology
Radiation oncology
Science education
Science education partnership (SEP)
Survivorship program

A standing gym trainer explains good form to a seated person lifting two small weights in their hands.
PROGRAMS AND SPECIALTIES HIGHLIGHT

Cancer Prevention and Early Detection

Our experts collaborate in the lab, clinic, and community to strengthen prevention and detection for all communities. We dig into environmental, genetic, and behavioral risk factors. Develop and test novel and less invasive screening and tracking methods. Find realistic ways to help people eat healthier, stop smoking, and access screening. And work to stop disease before it starts.

It means the world to me, and to our Fred Hutch researchers, clinicians, nurses, and patients, to know that this community partners with us to power the critical work we do.

Thomas J. Lynch Jr., MD, Fred Hutch President and Director and Raisbeck Endowed Chair

About Fred Hutch

Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat, and cure cancer and infectious diseases worldwide.

Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of innovation in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention, and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services. Fred Hutch also serves as UW Medicine’s cancer program. Learn more about Fred Hutch.

Beyond 50 mark

As we mark our 50th anniversary in 2025, Fred Hutch is looking beyond what’s possible today to a new era of discovery. With your partnership, our Campaign for Fred Hutch will transform the pace and scale of innovation so we can redefine cancer and infectious disease for generations to come.

The Vessel and the Arnold Building at Fred Hutch Cancer Center.
test

Who We Are

Fred Hutch counts on Obliteride dollars to advance bold discoveries and speed scientific innovation — and this community answers the call! We are bikers and walkers, individuals and teams, in-person and virtual participants, people who have experienced cancer and their families, and all those dedicated to curing cancer faster. Get to know a few members of our fundraising community.

Cyclist Darrell A. Rodgers, Sr., crosses the finish line.

Big Goal, Beloved Community 

When 100-mile rider Darrell A. Rodgers, Sr., heard about Obliteride at the golf course where he works, he signed up right away — and 140 of his coworkers and friends rallied behind him. “I finished treatment more than two decades ago. I never imagined I’d ride 100 miles and be a top fundraiser,” said Darrell. “My community was with me. The love and support were awesome. Let’s CRUSH cancer!”

Team Brian Dahl poses for a photo in matching purple shirts.

Continuing a Legacy

The Dahl family and their friends raised more than $54,000 to continue Brian Dahl’s legacy. “My dad, Brian, never let cancer impact his ability to share love and joy,” said team captain Spencer Dahl. “Even as his health worsened, he found Obliteride, set ambitious goals, and said ‘I can do that!’ I know he would feel blessed to know Team Brian Dahl is making a difference in others’ lives by fundraising for melanoma research!”

A person sits on a recumbent bike on a beach.

Connecting for Cures

“This is personal,” said virtual Obliterider and 11-year participant Kimberlee Hansen. “I’m 15 years cancer-free thanks to the massive efforts of dedicated doctors, researchers — and donors!” Together with her Freestone Capital colleagues, Kimberlee and Team Freestone increased their fundraising 146% from last year. They raised over $180,000 as Obliteride's top corporate team. “I want to live in a world where no one has to fear cancer,” Kimberlee said. “Fred Hutch’s research is how we’ll get there.”

Four volunteers pose happily together for a photo at Obliteride.

Camaraderie and Care

"The best thing about Obliteride is seeing how many people genuinely care about making a difference,” said volunteer Criostoir (Chris) Sausler. “The energy is amazing! The camaraderie between riders, runners, walkers, volunteers and Fred Hutch staff is so strong. I volunteer for many reasons, but the most important is to contribute to finding a cure for cancer. With enough people involved, and everyone giving what — and how — they can, we ARE, as a community, raising the money it takes.”

Team Hope Heroes poses for a group photo before starting the 5K.

Walking with Hope

“It’s about nursing excellence, community, and getting out there for every person who has or has had cancer,” says Denene Prophet-Williams, vice president and chief nursing officer at Fred Hutch and captain of team Hope Heroes. “Our clinic staff loved walking the 5K with our community and raising money to drive forward urgently needed advances and world-changing discoveries. Side by side for cures!”

Obliterider Ashley Best poses for a photo in front of the I Obliteride For wall.

Honor and Teamwork

Seven-year Obliterider Ashley Best walks for every person and family experiencing cancer. “My sweet mom lost her life to cancer in 2021,” she said. “I am thankful for her care team, but it leaves a hole in my heart to know other families go through what we went through. I Obliteride to change that. It was an honor to participate with colleagues and friends as the captain of Team Nordstrom. I am grateful for Nordstrom’s dedication to giving back to the communities where we live and work.”

I Obliteride to honor the courage of loved ones experiencing cancer. I'm proud to support Fred Hutch's cutting-edge research to obliterate it.

Steven Bley, six-year rider

United for Cures

No matter our speed, distance, or reason, we share one goal: To fundraise and help cure cancer faster. See us in action.

12 Years Strong

It all began in 2013, when a small group of cyclists started something BIG! They pedaled out to honor loved ones by fundraising for Fred Hutch. Today, our community of thousands of Obliteriders is united by the same passion: To cure cancer faster.

$58M+

Raised to support Fred Hutch

35,000+

Participants

119,000+

Donors

6,100+

Volunteers

Recognizing Our 12-Year Participants

These individuals have rallied their communities and made Obliteride special from our very first year. Their leadership is inspiring.

Patricia Aguilar
Geoff Anderson
John Barton
Gregory Berkman
Ruth Berkman
Tom Blumenstein
Steve Brooks
Carolyn Callaghan
Evanna Charlot
Larry Corey
James Crutcher

David Dapelo
Bob Davis
Julie di Furia
Jeff Dossett
Natalie Duerkopp
Hayley Duitch
Kevin Eckert
Frederick Fiene
Kristin Funston
Brad Glaberson
Nancy Greenwood Vehrs

Linda Helm
David Ignacio
Reid Jones
Brent Knudson
Amy Lavin
Kimberly Lengle
Rafferty Lengle
Jennifer Lester
Laura McQueen
Patrick McQueen
Rex Miller

Beth Mueller
Peter Nelson
Chris Nichols
Tristan Osborn
Owen Pearson
Mary Pettinger
Susie Plummer
Jerald Radich
Brett Robertson
Chad Robins
Darren Rozendaal

Michael Rubin
John Rumpeltes
Jai Russell
Pete Schneider
Alan Schulkin
Susan Schulkin
Stephen Schwartz
Stuart Sloan
Carey Smith
John Thelan
David Thompson

Christopher Varley
Patti Varley
Jeff Vehrs
Donald Wang
Sandy Ward
Margaret Weiland
Karin Yarbrough
Adam Zivin

Fred Hutch clinicians and researchers apply our Obliteride funds where they expect the most impact. That’s exciting!

Nina Milligan, 12-year Obliterider and volunteer

$1 Million Teams

Over 12 years, these outstanding teams have fundraised $1 million (and counting!) to fuel advances in research and care at Fred Hutch.

Team Lewis & Friends lines up in the starting chute.
$1,490,727

Lewis & Friends

Team Microsoft & Friends poses for a group photo.
$1,336,682

Microsoft & Friends

Members of the Village People team gear up to start their ride.
$1,404,241

Village People

Members from Team Amazon pose for a photo together.
$1,171,652

Amazon

Members from the Adaptive Biotechnologies team pose for a group photo.
$1,024,240

Adaptive Biotechnologies

Our Generous Sponsors

Special thanks to our sponsors and in-kind donors. Their dedication and support allow us to continue our promise that every participant-raised dollar will help Fred Hutch advance prevention, detection, treatment, and cures.

FOUNDING SPONSOR
sloan foundation logo
LEAD OUT SPONSOR
GLOBAL SPONSOR
VOLUNTEER SPONSOR

CENTURY SPONSORS
KING 5 logo
Sinegal Family Foundation logo

BREAK AWAY SPONSORS
Nordstrom logo
Pfizer logo
Sahsen Fund logo
Silver Cloud logo

DYNAMO SPONSORS
Alexandria Real Estate logo
Daiichi Sankyo logo
GLY logo
Lease Crutcher Lewis logo
SanMar logo

CADENCE SPONSORS

Aegis Living
AV Factory
Biolife Solutions
Freestone

REST STOP SPONSORS

BNBuilders
NBBJ
Prime Electric
SKANSKA
UMC


CLINK SPONSORS

Alaska Airlines
Compass Construction
Copiers Northwest
Thermo Fisher Scientific

IN-KIND DONORS

Ducleaux Cellars
Elysian Brewing
Talking Rain

Save the Date!

We can't wait to see you next year on Saturday, August 9, 2025!